| Commercialization of microfluidic devices LR Volpatti, AK Yetisen Trends in biotechnology 32 (7), 347-350, 2014 | 572 | 2014 |
| Photonic hydrogel sensors AK Yetisen, H Butt, LR Volpatti, I Pavlichenko, M Humar, SJJ Kwok, H Koo, ... Biotechnology advances 34 (3), 250-271, 2016 | 197 | 2016 |
| Glucose-responsive nanoparticles for rapid and extended self-regulated insulin delivery LR Volpatti, MA Matranga, AB Cortinas, D Delcassian, KB Daniel, ... ACS nano 14 (1), 488-497, 2019 | 156 | 2019 |
| Dual responsive, stabilized nanoparticles for efficient in vivo plasmid delivery H Wei, LR Volpatti, DL Sellers, DO Maris, IW Andrews, AS Hemphill, ... Angewandte Chemie (International ed. in English) 52 (20), 5377, 2013 | 144 | 2013 |
| A retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cells S Bose, LR Volpatti, D Thiono, V Yesilyurt, C McGladrigan, Y Tang, ... Nature biomedical engineering 4 (8), 814-826, 2020 | 141 | 2020 |
| Biomaterials for personalized cell therapy AL Facklam, LR Volpatti, DG Anderson Advanced materials 32 (13), 1902005, 2020 | 125 | 2020 |
| A clear view of polymorphism, twist, and chirality in amyloid fibril formation LR Volpatti, M Vendruscolo, CM Dobson, TPJ Knowles ACS nano 7 (12), 10443-10448, 2013 | 110 | 2013 |
| Microgel encapsulated nanoparticles for glucose-responsive insulin delivery LR Volpatti, AL Facklam, AB Cortinas, YC Lu, MA Matranga, C MacIsaac, ... Biomaterials 267, 120458, 2021 | 45 | 2021 |
| Patent protection and licensing in microfluidics AK Yetisen, LR Volpatti Lab on a Chip 14 (13), 2217-2225, 2014 | 45 | 2014 |
| Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity LR Volpatti, RP Wallace, S Cao, MM Raczy, R Wang, LT Gray, AT Alpar, ... ACS Central Science 7 (8), 1368–1380, 2021 | 36 | 2021 |
| Polymer physics inspired approaches for the study of the mechanical properties of amyloid fibrils LR Volpatti, TPJ Knowles Journal of Polymer Science Part B: Polymer Physics 52 (4), 281-292, 2014 | 32 | 2014 |
| Micro-and nanoscale hierarchical structure of core–shell protein microgels LR Volpatti, U Shimanovich, FS Ruggeri, S Bolisetty, T Müller, TO Mason, ... Journal of Materials Chemistry B 4 (48), 7989-7999, 2016 | 30 | 2016 |
| Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant LT Gray, MM Raczy, PS Briquez, TM Marchell, AT Alpar, RP Wallace, ... Biomaterials 278, 121159, 2021 | 29 | 2021 |
| Engineered insulin-polycation complexes for glucose-responsive delivery with high insulin loading LR Volpatti, DM Burns, A Basu, R Langer, DG Anderson Journal of Controlled Release 338, 71-79, 2021 | 20 | 2021 |
| Partially oxidized alginate as a biodegradable carrier for glucose‐responsive insulin delivery and islet cell replacement therapy LR Volpatti, MA Bochenek, AL Facklam, DM Burns, C MacIsaac, ... Advanced healthcare materials 12 (2), 2201822, 2023 | 13 | 2023 |
| Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity S Kang, A Mansurov, T Kurtanich, HR Chun, AJ Slezak, LR Volpatti, ... Science Advances 9 (48), eadh9879, 2023 | 7 | 2023 |
| Entrepreneurship AK Yetisen, LR Volpatti, AF Coskun, S Cho, E Kamrani, H Butt, ... Lab Chip 15, 3638-3660, 2015 | 7* | 2015 |
| Biocompatible microfabricated macrodevices for transplanting cells B Suman, V Yesilyurt, LR Volpatti, RS Langer, DG Anderson US Patent App. 16/007,922, 2018 | 6 | 2018 |
| Promoting an Inclusive Lab Culture through Custom In-Person Trainings within an Engineering Department LR Volpatti, K Rodby, GK Singh, B Kaushal, KM Adams, PT Hammond, ... 2020 ASEE Virtual Annual Conference Content Access, https://peer.asee.org/35102, 2020 | 1 | 2020 |
| Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy S Kang, A Mansurov, T Kurtanich, HR Chun, AJ Slezak, LR Volpatti, ... Journal for immunotherapy of cancer 12 (12), e009541, 2024 | | 2024 |
